课题基金 / 基金详情

HEAT SHOCK PROTEIN FUNCTION AS A THERAPEUTIC TARGET

HEAT SHOCK PROTEIN FUNCTION AS A THERAPEUTIC TARGET
热休克蛋白功能作为治疗靶点
批准号:
2700656
负责人:
LUKE J WHITESELL
金额:
$10.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-05-01 至 2001-04-30

项目摘要

项目成果

LUKE J WHITESELL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: The investigator's recent studies have implicated the selective interaction of geldanamycin (GA) with certain cellular heat shock proteins in mediating anti-tumor activity, but the specific molecular consequences of this interaction in clinically relevant tumor models remain unclear. In this application, studies are proposed which will examine GA effects on the assembly and function of two heat shock protein-containing multimolecular complexes known to be important in the biology of many breast cancers; namely, the estrogen receptor (ER) and mutant p53. Reconstitution experiments using reticulocyte lysate will be used to identify the specific components of the ER and p53 complexes and assess drug effects on the dynamics of complex assembly. At the whole-cell level, GA effects on steady state-expression, subcellular localization and transcriptional transactivating activity of the two targets will be examined. Lastly, p53 and ER expression will be examined in breast tumor xenografts growing in SCID mice treated with GA. These experiments should define useful biologic endpoints for drug action in vivo and will allow assessment of the significance of the molecular effects observed in tissue culture for tumorigenicity in animals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating Abeta and alpha-synuclein toxicity by analyzing single-cell dynamic
Identifying species-specific anti-malarial Hsp90 inhibitors using genetically eng
Identifying species-specific anti-malarial Hsp90 inhibitors using genetically eng
Identifying Small Molecules To Probe the Role of Heat Shock Factor 1 in Cancer
海外基金